Breast Cancer (Diagnostics)

High-Definition Ultrasound Approved by FDA

Published in Women's Health Weekly, April 22nd, 1996

The U.S. Food and Drug Administration (FDA) approved High-Definition Imaging (HDI) ultrasound which will assist doctors in determining when lumps in women's breasts are benign.

Advanced Technology Laboratories (ATL), Seattle, Washington, predicts its HDI ultrasound eventually will cut by 40 percent the 700,000 breast biopsies performed annually in the U.S. Of those biopsies, 180,000 will be diagnosed as cancerous. The remainder will be diagnosed as benign lumps.

A biopsy costs about $2,500, while the 15-minute, ultrasound will cost $75 to $300, ATL said.

"No test is 100 percent, although this is very close," said Dr. Brian...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (1996-04-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry